Gene · 29927
Papers2,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the ER channel protein Sec61: recent advances in pathophysiological significance and novel pharmacological inhibitors. | Front Pharmacol | 2025 | 40535761 | PubTator, text mining | PubMed |
| Effect of glycosylation on protein folding: From biological roles to chemical protein synthesis. | iScience | 2025 | 40502693 | PubTator, text mining | PubMed |
| ATP13A1 engages SEC61 to facilitate substrate-specific translocation. | Sci Adv | 2025 | 40498833 | PubTator, text mining | PubMed |
| Single-cell transcriptomic profiling reveals dysregulation of B-cell subset function in patients with chronic hepatitis B. | Hepatol Int | 2025 | 40489024 | PubTator, text mining | PubMed |
| Endolysosomal engulfment of autophagosomes independent of ESCRT. | Biochem Biophys Res Commun | 2025 | 40414004 | PubTator, text mining | PubMed |
| SEC61G promotes colorectal cancer progression by regulating cytosolic Ca2+ concentration. | J Gastroenterol | 2025 | 40413702 | PubTator, text mining | PubMed |
| Protein targeting to the ER membrane: multiple pathways and shared machinery. | Crit Rev Biochem Mol Biol | 2025 | 40377270 | PubTator, text mining | PubMed |
| Mechanical effect of protein glycosylation on BiP-mediated post-translational translocation and folding in the endoplasmic reticulum. | Biophys Rev | 2025 | 40376427 | PubTator, text mining | PubMed |
| Application of biomarkers in the diagnosis of kidney disease. | Front Med (Lausanne) | 2025 | 40370722 | PubTator, text mining | PubMed |
| Emerging Patterns in Membrane Protein Folding Pathways. | Annu Rev Biophys | 2025 | 40327440 | PubTator, text mining | PubMed |
| Lipid Scrambling Pathways in the Sec61 Translocon Complex. | J Am Chem Soc | 2025 | 40325981 | PubTator, text mining | PubMed |
| Defective gating of the Sec61 translocon results in reorganisation of the actin cytoskeleton and perturbed formation of the actomyosin contractile ring. | Biochim Biophys Acta Mol Cell Res | 2025 | 40112953 | PubTator, text mining | PubMed |
| Integrative Analysis of scRNA-Seq and Bulk RNA-Seq Identifies Plasma Cell Related Genes and Constructs a Prognostic Model for Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2025 | 40040881 | PubTator, text mining | PubMed |
| SEC61G Facilitates Brain Metastases via Antagonizing PGAM1 Ubiquitination and Immune Microenvironment Remodeling in Non-Small Cell Lung Cancer. | Int J Biol Sci | 2025 | 39990664 | PubTator, text mining | PubMed |
| UPLC-TOF-MS/MDF oriented isolation of calonyctins K-R: Resin glycosides from Ipomoea muricata with cytotoxic and multidrug resistance reversal activities. | Phytochemistry | 2025 | 39986411 | PubTator, text mining | PubMed |
| Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort. | Clin Exp Nephrol | 2025 | 39976632 | PubTator, text mining | PubMed |
| The Mycobacterium ulcerans toxin mycolactone causes destructive Sec61-dependent loss of the endothelial glycocalyx and vessel basement membrane to drive skin necrosis. | Elife | 2025 | 39913180 | PubTator, text mining | PubMed |
| Structural Modifications Reveal Dual Functions of the C-4 Carbonyl Group in the Fatty Acid Chain of Ipomoeassin F. | Molecules | 2025 | 39860269 | PubTator, text mining | PubMed |
| Mutations in histones dysregulate copper homeostasis leading to defect in Sec61-dependent protein translocation mechanism in Saccharomyces cerevisiae. | J Biol Chem | 2025 | 39793894 | PubTator, text mining | PubMed |
| A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma. | Cell Death Differ | 2025 | 39690246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29927/papers?page=3